Your browser doesn't support javascript.
loading
Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee.
Thunnissen, Erik; Beasley, Mary Beth; Borczuk, Alain; Dacic, Sanja; Kerr, Keith M; Lissenberg-Witte, Birgit; Minami, Yuko; Nicholson, Andrew G; Noguchi, Masayuki; Sholl, Lynette; Tsao, Ming-Sound; Le Quesne, John; Roden, Anja C; Chung, Jin-Haeng; Yoshida, Akihiko; Moreira, Andre L; Lantuejoul, Sylvie; Pelosi, Giuseppe; Poleri, Claudia; Hwang, David; Jain, Deepali; Travis, William D; Brambilla, Elisabeth; Chen, Gang; Botling, Johan; Bubendorf, Lukas; Mino-Kenudson, Mari; Motoi, Noriko; Chou, Teh Ying; Papotti, Mauro; Yatabe, Yasushi; Cooper, Wendy.
Afiliación
  • Thunnissen E; Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: e.thunnissen@amsterdamumc.nl.
  • Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Borczuk A; Department of Pathology, Northwell Health, Greenvale, New York.
  • Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Kerr KM; Department of Pathology, Aberdeen University School of Medicine and Aberdeen Royal Infirmary, Aberdeen, Scotland.
  • Lissenberg-Witte B; Amsterdam UMC location Vrije Universiteit, Department of Epidemiology and Data Science, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Minami Y; Department of Pathology, National Hospital Organization Ibarakihigashi National Hospital The Center of Chest Diseases and Severe Motor & Intellectual Disabilities, Tokai, Ibaraki, Japan.
  • Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Noguchi M; Department of Pathology, Narita Tomisato Tokushukai Hospital and Tokushukai East Pathology Center, Tsukuba, Japan.
  • Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Tsao MS; Department of Pathology, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Le Quesne J; Beatson Cancer Research Institute, University of Glasgow, NHS Greater Glasgow and Clyde Glasgow, Glasgow, United Kingdom.
  • Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Chung JH; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Moreira AL; Department of Pathology, NYU Grossman School of Medicine, New York, New York.
  • Lantuejoul S; Department of Biopathology, Leon Berard Cancer Center and CRCL INSERM U 1052, Lyon, and Grenoble Alpes University, Lyon, France.
  • Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Inter-Hospital Pathology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy.
  • Poleri C; Office of Pathology Consultants, Buenos Aires, Argentina.
  • Hwang D; Sunnybrook Health Sciences Centre, Odette Cancer Centre, Ontario, Canada.
  • Jain D; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brambilla E; Grenoble, France.
  • Chen G; Hongshan Hospital Fudan University, Shanghai, People's Republic of China.
  • Botling J; Uppsala University Hospital, Uppsala, Sweden.
  • Bubendorf L; University Hospital Basel, Basel, Switzerland.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Motoi N; Saitama Cancer Center, Saitama, Japan.
  • Chou TY; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Papotti M; Department of Oncology, University of Turin, Torino, Italy.
  • Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Cooper W; Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, NSW, Australia.
J Thorac Oncol ; 18(4): 447-462, 2023 04.
Article en En | MEDLINE | ID: mdl-36503176
ABSTRACT

INTRODUCTION:

Since the eight edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM classification system, the primary tumor pT stage is determined on the basis of presence and size of the invasive components. The aim of this study was to identify histologic features in tumors with lepidic growth pattern which may be used to establish criteria for distinguishing invasive from noninvasive areas.

METHODS:

A Delphi approach was used with two rounds of blinded anonymized analysis of resected nonmucinous lung adenocarcinoma cases with presumed invasive and noninvasive components, followed by one round of reviewer de-anonymized and unblinded review of cases with known outcomes. A digital pathology platform was used for measuring total tumor size and invasive tumor size.

RESULTS:

The mean coefficient of variation for measuring total tumor size and tumor invasive size was 6.9% (range 1.7%-22.3%) and 54% (range 14.7%-155%), respectively, with substantial variations in interpretation of the size and location of invasion among pathologists. Following the presentation of the results and further discussion among members at large of the International Association for the Study of Lung Cancer Pathology Committee, extensive epithelial proliferation (EEP) in areas of collapsed lepidic growth pattern is recognized as a feature likely to be associated with invasive growth. The EEP is characterized by multilayered luminal epithelial cell growth, usually with high-grade cytologic features in several alveolar spaces.

CONCLUSIONS:

Collapsed alveoli and transition zones with EEP were identified by the Delphi process as morphologic features that were a source of interobserver variability. Definition criteria for collapse and EEP are proposed to improve reproducibility of invasion measurement.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article